4//SEC Filing
Selkoe Dennis J. 4
Accession 0001567619-22-000673
CIK 0001559053other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 9:02 PM ET
Size
13.8 KB
Accession
0001567619-22-000673
Insider Transaction Report
Form 4
Selkoe Dennis J.
Director
Transactions
- Sale
Ordinary Shares, par value $0.01 per share
2022-01-03$46.81/sh−2,133$99,836→ 5,712 total - Sale
Ordinary Shares, par value $0.01 per share
2022-01-03$49.48/sh−492$24,343→ 2,845 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-01-03+5,000→ 6,000 totalExercise: $9.23From: 2020-05-18Exp: 2029-05-22→ Ordinary Shares (5,000 underlying) - Exercise/Conversion
Ordinary Shares, par value $0.01 per share
2022-01-03$9.23/sh+5,000$46,150→ 7,845 total - Sale
Ordinary Shares, par value $0.01 per share
2022-01-03$47.60/sh−2,375$113,054→ 3,337 total
Holdings
- 1,363(indirect: By Spouse)
Ordinary Shares, par value $0.01 per share
Footnotes (4)
- [F1]The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The transaction was executed in multiple trades in prices ranging from $46.30 to $47.26, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]The transaction was executed in multiple trades in prices ranging from $47.30 to $48.08, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F4]The transaction was executed in multiple trades in prices ranging from $49.03 to $49.77, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
PROTHENA CORP PUBLIC LTD CO
CIK 0001559053
Entity typeother
Related Parties
1- filerCIK 0001582306
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 9:02 PM ET
- Size
- 13.8 KB